CAMK2G and diabetes mellitus: Whilst many antioxidants have been shown to downregulate CaMKII pathways (e.g. resveratrol downregulates CaMKII in neurons), disappointingly untargeted antioxidant therapy has not been shown to therapeutically and materially affect outcomes, especially in diabetes [164].